This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
Panelists discuss how pharmacists, through frequent patient contact and vigilant observation, are uniquely positioned to identify early signs of tardive dyskinesia, conduct AIMS assessments, monitor treatment efficacy, foster patient trust, and provide crucial education to support timely intervention and improve long-term management outcomes.
Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.
Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Numerous types of formulations can be used to create pharmaceuticals, such as solid dosage forms, liquid dispersions, gel through to creams. Drug development professionals should consider relevant factors including the intended patients and application, properties of the raw materials and more. As such, those working in the sector must maintain awareness of the latest developments to optimise processes, ensure compliance and that a safe, high-quality product is produced.
Pharmacists do a lot more than just count pills behind the counter. They’re important healthcare professionals who can greatly influence how patients take care of their health. Building strong relationships with patients not only helps with medication adherence but also makes work more rewarding for pharmacists. Creating meaningful relationships doesn’t have to take a lot of time, even for pharmacists with busy schedules.
Namrata Shah, MD, discusses the groundbreaking efficacy and patient-centered potential of twice-yearly lenacapavir for HIV pre-exposure prophylaxis (PrEP), supported by pivotal data from the PURPOSE trials.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Namrata Shah, MD, discusses the groundbreaking efficacy and patient-centered potential of twice-yearly lenacapavir for HIV pre-exposure prophylaxis (PrEP), supported by pivotal data from the PURPOSE trials.
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Ovagen breakthrough boosts yellow fever vaccine yields by John Pinching | 23rd Jul 2025 | News Irish biotech’s germ-free egg platform could help close global shortfall Irish biotech Ovagen has announced a major advance in vaccine manufacturing, with new data showing its germ-free embryonated eggs can produce
New regulation enforced by the Medicines and Healthcare products Regulatory Agency (MHRA), means the UK is the first country to introduce a legal framework enabling cutting-edge personalised medicines to be manufactured at point of care. These therapies, such as CAR-T cancer therapy, have previously been produced in specialist facilities often far away from patients, resulting in treatment delays.
Imagine trying to navigate a busy city without a GPS. That’s how modern pharma marketing would feel without social media analytics. In an era where every scroll, like, and comment reveals intent, understanding and measuring digital interactions is no longer optional—it’s mission-critical. As pharmaceutical marketers seek better ways to personalize content, boost ROI, and remain compliant, social media analytics emerges as the compass guiding informed decisions.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Panelists discuss how pharmacists play a vital role in managing tardive dyskinesia by conducting regular AIMS assessments, supporting medication adherence and tolerability, collaborating with health care teams, and integrating standardized monitoring into clinical workflows to enable early detection and optimize patient outcomes across care settings.
Since 2014, the three largest pharmacy benefit managers (PBMs) have excluded 1,584% more medicines from commercial formularies, according to a new report from Cencora. Formularies are the lists of medicines covered in commercial health plans, often organized into tiers. The report highlights a concerning trend: the average annual increase in medications being excluded from formularies was 27%.
The upcoming financial quarter for the pharmaceutical industry is set to see changes driven by “innovation, competitive positioning, and regulatory momentum”, according to a report by GlobalData. Key influences include late-stage clinical trial results and regulatory decisions by the US Food and Drug Administration (FDA). In the current quarter, the US agency approved the first new on-demand treatment for hereditary angioedema (HAE) in over a decade.
The pharmaceutical world never sleeps. From FDA approvals to policy shifts and AI-driven innovations, every week brings changes that could redefine patient outcomes and market strategies. But how do you know which pharma news stories matter most? Think of the industry as a fast-moving river—keeping up means knowing where the currents are headed. In this article, we spotlight critical pharmaceutical developments, innovations, and marketing trends you need to monitor to stay competitive.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Addressing harassment, strengthening leadership, and involving frontline pharmacy staff in decision-making are key steps toward a healthier, more supportive work environment.
An expert discusses how pharmacists can expand their role in chronic myeloid leukemia (CML) care through remote medication therapy management, adherence support, and helping patients navigate insurance barriers and medication access challenges to ensure successful long-term treatment outcomes.
As demand for personalised treatments grows, 3D printing is transforming pharmaceutical development with unmatched precision and adaptability. This shift away from ward-based manipulations of medication is especially vital in paediatrics, where accurate dosing and child-friendly formulations are crucial for safe and effective care, as Mattias Paulsson explains.
Sanofi has agreed to acquire the biotech Vicebio for an upfront payment of $1.15 billion, supporting the advancement of respiratory virus vaccines. In addition to the initial payment, Sanofi will pay up to $450 million, subject to achieved development and regulatory milestones. The deal intends to expand capabilities in vaccine design and development and will enable Sanofi to add a non-mRNA vaccine to its development pipeline.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Understanding pharma marketing today means understanding its data points. Like a physician interpreting lab results, marketers must analyze campaign metrics to make informed decisions. But which numbers truly matter? And how can they be used to build successful brand strategies? In this article, we explore the data points that define pharmaceutical marketing—those that guide strategic decisions, influence healthcare professional (HCP) behavior, and enhance patient engagement.
Pharmacists play a key role in monitoring insulin use by addressing dosing, storage, and symptom management through regular, supportive patient check-ins.
Debra Patt, MD, PhD, MBA, and Houston Holmes, MD, explore how the removal of risk evaluation and management strategies (REMS) for chimeric antigen receptor (CAR) T-cell (CAR T) therapies can improve health equity, expand access in community settings, and elevate the pharmacist’s role in care coordination.
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer
These innovations are revolutionizing pharmaceutical packaging by enhancing drug safety, combating counterfeiting, ensuring regulatory compliance, and improving patient adherence across the supply chain.
Pharmacists can improve insulin safety and adherence by combining in-person counseling with practical tools, regular check-ins, and proactive education.
The decentralization of US health care, accelerated by virtual care adoption, shifting reimbursement models, and a growing demand for complex therapies, is elevating the role of specialty and infusion pharmacies as essential, tech-enabled partners in delivering coordinated, patient-centered care across outpatient and home-based settings.
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Exonate to launch phase 2b trial of EXN407 for diabetic eye disease by John Pinching | 29th Jul 2025 | News CLEAR-DE study to assess topical therapy for non-proliferative diabetic retinopathy Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibi
What happens when an industry known for regulation meets one driven by innovation? That’s the crossroads pharma marketing faces today. As digital-first engagement accelerates and patient expectations rise, marketers must navigate a sea of compliance, data privacy laws, and eroding trust. This article explores the key Pharma Marketing Challenges that define 2025—and what pharma brands must do to stay relevant, effective, and compliant.
AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibody-drug conjugate (ADC) approved in the country for treating folate receptor-alpha (FRα) high, platinum-resistant ovarian cancer.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership PhoreMost unveils platform to streamline molecular glue drug discovery by John Pinching | 22nd Jul 2025 | News GlueSEEKER enables rational design of targeted protein degraders PhoreMost has published new data validating its GlueSEEKER platform, a high-throughput technology designed to accelerate molecular glu
Artificial intelligence is transforming pharmaceutical marketing with unprecedented precision. But with that power comes responsibility—especially when it comes to patient privacy. As pharma brands race to personalize engagement and optimize digital strategies, they face growing scrutiny over how data is collected, stored, and used. How do marketers walk the tightrope between innovation and compliance?
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content